                               SEQUENCE LISTING

<110> ATRECA, INC.
 
<120> ANTI-HIV ANTIBODIES

<130> 097519-1126780 (1310WO)

<140> PCT/US2019/021495
<141> 2019-03-08

<150> 62/641,212
<151> 2018-03-09

<160> 38    

<170> PatentIn version 3.5

<210> 1
<211> 128
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 1
Ala Gly Leu Met Gln Ser Gly Ala Val Met Lys Asn Ser Gly Ala Ser 
1               5                   10                  15      


Val Arg Val Ser Cys Gln Ala Asp Gly Tyr Asp Phe Ile Asp Tyr Val 
            20                  25                  30          


Ile His Trp Phe Arg Gln Arg Arg Gly Glu Gly Leu Glu Trp Leu Gly 
        35                  40                  45              


Trp Met Asn Pro Ser Gly Gly Gly Thr Asn Tyr Pro Arg Pro Phe Gln 
    50                  55                  60                  


Gly Lys Val Thr Met Thr Arg Asp Thr Ser Thr Glu Thr Ala Tyr Leu 
65                  70                  75                  80  


Asp Val Arg Gly Leu Thr Tyr Asp Asp Thr Ala Val Tyr Tyr Cys Val 
                85                  90                  95      


Arg Asp Arg Ala Asn Gly Ser Gly Arg Arg Arg Phe Glu Ser Val Asn 
            100                 105                 110         


Trp Phe Leu Asp Leu Trp Gly Arg Gly Thr Gln Ile Thr Val Val Ser 
        115                 120                 125             


<210> 2
<211> 99
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 2
Gln Ser Ala Leu Thr Gln Pro Arg Ser Val Ser Ala Ser Pro Gly Gln 
1               5                   10                  15      


Ser Val Thr Ile Ser Cys Thr Gly Thr His Asn Tyr Val Ser Trp Cys 
            20                  25                  30          


Gln Gln Lys Pro Gly Gln Ala Pro Lys Leu Leu Ile Tyr Asp Phe Asn 
        35                  40                  45              


Lys Arg Pro Ser Gly Val Ser Asp Arg Phe Ser Gly Ser Thr Ser Gly 
    50                  55                  60                  


Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu Gln Ala Asp Asp Glu Gly 
65                  70                  75                  80  


His Tyr Phe Cys Trp Ala Phe Glu Asn Ile Gly Gly Gly Thr Lys Leu 
                85                  90                  95      


Thr Val Leu 
            


<210> 3
<211> 128
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 3
Ser Ala Glu Leu Val Gln Ser Gly Ala Val Val Lys Lys Pro Gly Thr 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Gln Ala Tyr Gly Tyr Thr Phe Thr Asp Tyr 
            20                  25                  30          


Leu Ile His Trp Leu Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Met Asn Pro Val Tyr Gly Gln Val Asn Tyr Ala Gln Asn Phe 
    50                  55                  60                  


Gln Gly Arg Val Ser Met Thr Arg Asp Ile Tyr Arg Glu Thr Ala Phe 
65                  70                  75                  80  


Leu Glu Val Arg Asp Leu Lys Thr Asp Asp Thr Gly Thr Tyr Tyr Cys 
                85                  90                  95      


Val Arg Asp Thr Gly Asp Gly Ser Arg Arg His Phe Asp Ser Ile Asn 
            100                 105                 110         


Trp Phe Leu Asp Leu Trp Gly Arg Gly Thr Trp Ile Arg Val Ala Pro 
        115                 120                 125             


<210> 4
<211> 99
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 4
Gln Cys Val Leu Thr Gln Pro Arg Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Val Thr Ile Ser Cys Thr Gly Thr His Asn Tyr Val Ser Trp Cys 
            20                  25                  30          


Gln His His Pro Gly Asn Ala Pro Lys Leu Leu Leu Tyr Asp Phe Asp 
        35                  40                  45              


Lys Arg Pro Ser Gly Ile Ser Asp Arg Phe Ser Gly Ser Arg Ser Gly 
    50                  55                  60                  


Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu Gln Pro Glu Asp Glu Ala 
65                  70                  75                  80  


Asp Tyr Phe Cys Trp Ala Phe Glu Ala Phe Gly Gly Gly Thr Lys Val 
                85                  90                  95      


Leu Val Leu 
            


<210> 5
<211> 120
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 5
His Val Gln Leu Val Gln Ser Gly Gly Gly Val Lys Lys Ile Gly Ala 
1               5                   10                  15      


Ala Val Arg Ile Ser Cys Glu Val Thr Gly Tyr Lys Phe Met Asp Gln 
            20                  25                  30          


Leu Ile Asn Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Met Asn Pro Thr Tyr Gly Gln Val Asn Tyr Ser Trp Arg Phe 
    50                  55                  60                  


Glu Gly Arg Val Thr Met Thr Arg Asp Met Asp Thr Glu Thr Ala Phe 
65                  70                  75                  80  


Met Glu Leu Arg Gly Leu Arg Val Asp Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Pro Ser Gly Glu Asn Tyr Pro Phe His Tyr Trp Gly Gln 
            100                 105                 110         


Gly Val Arg Val Val Val Ser Ser 
        115                 120 


<210> 6
<211> 100
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 6
Ala Ser Ala Leu Thr Gln Pro Ala Ser Met Ser Ala Ser Pro Gly Gln 
1               5                   10                  15      


Ser Val Thr Ile Ser Cys Ser Gly Thr Arg His Ile Ile Ser Ala Trp 
            20                  25                  30          


Phe Gln Gln Tyr Pro Gly Lys Pro Pro Lys Leu Ile Ile Phe Asp Asp 
        35                  40                  45              


Asp Lys Arg Pro Ser Gly Val Pro Ser Arg Phe Ser Ala Ser Arg Pro 
    50                  55                  60                  


Gly Asp Thr Ala Ser Leu Thr Ile Ser Asn Val Gln Pro Glu Asp Glu 
65                  70                  75                  80  


Ala Thr Tyr Ile Cys Asn Thr Tyr Glu Phe Phe Gly Gly Gly Thr Arg 
                85                  90                  95      


Leu Thr Val Leu 
            100 


<210> 7
<211> 120
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 7
His Val Gln Leu Val Gln Ser Gly Gly Gly Val Lys Lys Ile Gly Ala 
1               5                   10                  15      


Ala Val Arg Ile Ser Cys Glu Val Thr Gly Tyr Lys Phe Met Asp Gln 
            20                  25                  30          


Leu Ile Asn Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Met Asn Pro Thr Tyr Gly Gln Val Gln Tyr Ser Trp Arg Phe 
    50                  55                  60                  


Glu Gly Arg Val Thr Met Thr Arg Asp Met Asp Thr Glu Thr Ala Phe 
65                  70                  75                  80  


Met Glu Leu Arg Gly Leu Arg Val Asp Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Pro Ser Gly Glu Asn Tyr Pro Phe His Tyr Trp Gly Gln 
            100                 105                 110         


Gly Val Arg Val Val Val Ser Ser 
        115                 120 


<210> 8
<211> 120
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 8
His Val Gln Leu Val Gln Ser Gly Gly Gly Val Lys Lys Ile Gly Ala 
1               5                   10                  15      


Ala Val Arg Ile Ser Cys Glu Val Thr Gly Tyr Lys Phe Met Asp Gln 
            20                  25                  30          


Leu Ile Asn Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Met Asn Pro Thr Tyr Gly Gln Val Asp Tyr Ser Trp Arg Phe 
    50                  55                  60                  


Glu Gly Arg Val Thr Met Thr Arg Asp Met Asp Thr Glu Thr Ala Phe 
65                  70                  75                  80  


Met Glu Leu Arg Gly Leu Arg Val Asp Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Pro Ser Gly Glu Asn Tyr Pro Phe His Tyr Trp Gly Gln 
            100                 105                 110         


Gly Val Arg Val Val Val Ser Ser 
        115                 120 


<210> 9
<211> 120
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 9
His Val Gln Leu Val Gln Ser Gly Gly Gly Val Lys Lys Ile Gly Ala 
1               5                   10                  15      


Ala Val Arg Ile Ser Cys Glu Val Thr Gly Tyr Lys Phe Met Asp Gln 
            20                  25                  30          


Leu Ile Asn Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Met Asn Pro Thr Tyr Gly Gln Val Ser Tyr Ser Trp Arg Phe 
    50                  55                  60                  


Glu Gly Arg Val Thr Met Thr Arg Asp Met Asp Thr Glu Thr Ala Phe 
65                  70                  75                  80  


Met Glu Leu Arg Gly Leu Arg Val Asp Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Pro Ser Gly Glu Asn Tyr Pro Phe His Tyr Trp Gly Gln 
            100                 105                 110         


Gly Val Arg Val Val Val Ser Ser 
        115                 120 


<210> 10
<211> 120
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 10
His Val Gln Leu Val Gln Ser Gly Gly Gly Val Lys Lys Ile Gly Ala 
1               5                   10                  15      


Ala Val Arg Ile Ser Cys Glu Val Thr Gly Tyr Lys Phe Met Asp Gln 
            20                  25                  30          


Leu Ile Asn Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Met Asn Pro Thr Tyr Gly Gln Val Ala Tyr Ser Trp Arg Phe 
    50                  55                  60                  


Glu Gly Arg Val Thr Met Thr Arg Asp Met Asp Thr Glu Thr Ala Phe 
65                  70                  75                  80  


Met Glu Leu Arg Gly Leu Arg Val Asp Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Pro Ser Gly Glu Asn Tyr Pro Phe His Tyr Trp Gly Gln 
            100                 105                 110         


Gly Val Arg Val Val Val Ser Ser 
        115                 120 


<210> 11
<211> 120
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 11
His Val Gln Leu Val Gln Ser Gly Gly Gly Val Lys Lys Ile Gly Ala 
1               5                   10                  15      


Ala Val Arg Ile Ser Cys Glu Val Thr Gly Tyr Lys Phe Met Asp Gln 
            20                  25                  30          


Leu Ile Asn Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Met Asn Pro Thr Tyr Gly Gln Val Asn Tyr Ala Trp Arg Phe 
    50                  55                  60                  


Glu Gly Arg Val Thr Met Thr Arg Asp Met Asp Thr Glu Thr Ala Phe 
65                  70                  75                  80  


Met Glu Leu Arg Gly Leu Arg Val Asp Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Pro Ser Gly Glu Asn Tyr Pro Phe His Tyr Trp Gly Gln 
            100                 105                 110         


Gly Val Arg Val Val Val Ser Ser 
        115                 120 


<210> 12
<211> 120
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 12
His Val Gln Leu Val Gln Ser Gly Gly Gly Val Lys Lys Ile Gly Ala 
1               5                   10                  15      


Ala Val Arg Ile Ser Cys Glu Val Thr Gly Tyr Lys Phe Met Asp Gln 
            20                  25                  30          


Leu Ile Asn Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Met Asn Pro Thr Tyr Gly Gln Val Asn Tyr Asn Trp Arg Phe 
    50                  55                  60                  


Glu Gly Arg Val Thr Met Thr Arg Asp Met Asp Thr Glu Thr Ala Phe 
65                  70                  75                  80  


Met Glu Leu Arg Gly Leu Arg Val Asp Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Gly Pro Ser Gly Glu Asn Tyr Pro Phe His Tyr Trp Gly Gln 
            100                 105                 110         


Gly Val Arg Val Val Val Ser Ser 
        115                 120 


<210> 13
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 13
Gly Tyr Asp Phe Ile Asp Tyr Val Ile His 
1               5                   10  


<210> 14
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 14
Trp Met Asn Pro Ser Gly Gly Gly Thr Asn Tyr Pro Arg Pro Phe Gln 
1               5                   10                  15      


Gly 
    


<210> 15
<211> 22
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 15
Val Arg Asp Arg Ala Asn Gly Ser Gly Arg Arg Arg Phe Glu Ser Val 
1               5                   10                  15      


Asn Trp Phe Leu Asp Leu 
            20          


<210> 16
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 16
Thr Gly Thr His Asn Tyr Val Ser 
1               5               


<210> 17
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 17
Asp Phe Asn Lys Arg Pro Ser 
1               5           


<210> 18
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 18
Trp Ala Phe Glu Asn 
1               5   


<210> 19
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 19
Gly Tyr Thr Phe Thr Asp Tyr Leu Ile His 
1               5                   10  


<210> 20
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 20
Trp Met Asn Pro Val Tyr Gly Gln Val Asn Tyr Ala Gln Asn Phe Gln 
1               5                   10                  15      


Gly 
    


<210> 21
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 21
Val Arg Asp Thr Gly Asp Gly Ser Arg Arg His Phe Asp Ser Ile Asn 
1               5                   10                  15      


Trp Phe Leu Asp Leu 
            20      


<210> 22
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 22
Asp Phe Asp Lys Arg Pro Ser 
1               5           


<210> 23
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 23
Trp Ala Phe Glu Ala 
1               5   


<210> 24
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 24
Gly Tyr Lys Phe Met Asp Gln Leu Ile Asn 
1               5                   10  


<210> 25
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 25
Trp Met Asn Pro Thr Tyr Gly Gln Val Asn Tyr Ser Trp Arg Phe Glu 
1               5                   10                  15      


Gly 
    


<210> 26
<211> 13
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 26
Ala Arg Gly Pro Ser Gly Glu Asn Tyr Pro Phe His Tyr 
1               5                   10              


<210> 27
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 27
Ser Gly Thr Arg His Ile Ile Ser Ala 
1               5                   


<210> 28
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 28
Asp Asp Asp Lys Arg Pro Ser 
1               5           


<210> 29
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 29
Asn Thr Tyr Glu Phe 
1               5   


<210> 30
<211> 127
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 30
Ala Asp Leu Val Gln Ser Gly Ala Val Val Lys Lys Pro Gly Asp Ser 
1               5                   10                  15      


Val Arg Ile Ser Cys Glu Ala Gln Gly Tyr Arg Phe Pro Asp Tyr Ile 
            20                  25                  30          


Ile His Trp Ile Arg Arg Ala Pro Gly Gln Gly Pro Glu Trp Met Gly 
        35                  40                  45              


Trp Met Asn Pro Met Gly Gly Gln Val Asn Ile Pro Trp Lys Phe Gln 
    50                  55                  60                  


Gly Arg Val Ser Met Thr Arg Asp Thr Ser Ile Glu Thr Ala Phe Leu 
65                  70                  75                  80  


Asp Leu Arg Gly Leu Lys Ser Asp Asp Thr Ala Val Tyr Tyr Cys Val 
                85                  90                  95      


Arg Asp Arg Ser Asn Gly Ser Gly Lys Arg Phe Glu Ser Ser Asn Trp 
            100                 105                 110         


Phe Leu Asp Leu Trp Gly Arg Gly Thr Ala Val Thr Ile Gln Ser 
        115                 120                 125         


<210> 31
<211> 98
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 31
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala 
1               5                   10                  15      


Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Gly Tyr 
            20                  25                  30          


Tyr Met His Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met 
        35                  40                  45              


Gly Trp Ile Asn Pro Asn Ser Gly Gly Thr Asn Tyr Ala Gln Lys Phe 
    50                  55                  60                  


Gln Gly Arg Val Thr Met Thr Arg Asp Thr Ser Ile Ser Thr Ala Tyr 
65                  70                  75                  80  


Met Glu Leu Ser Arg Leu Arg Ser Asp Asp Thr Ala Val Tyr Tyr Cys 
                85                  90                  95      


Ala Arg 
        


<210> 32
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 32
Tyr Tyr Tyr Gly Ser Gly Ser Tyr Tyr Asn 
1               5                   10  


<210> 33
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 33
Tyr Trp Tyr Phe Asp Leu Trp Gly Arg Gly Thr Leu Val Thr Val Ser 
1               5                   10                  15      


Ser 
    


<210> 34
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 34
Tyr Phe Asp Tyr Trp Gly Gln Gly Thr Leu Val Thr Val Ser Ser 
1               5                   10                  15  


<210> 35
<211> 99
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 35
Gln Ser Ala Leu Thr Gln Pro Arg Ser Val Ser Ala Ser Pro Gly Gln 
1               5                   10                  15      


Ser Val Thr Ile Ser Cys Thr Gly Thr His Asn Leu Val Ser Trp Cys 
            20                  25                  30          


Gln His Gln Pro Gly Arg Ala Pro Lys Leu Leu Ile Tyr Asp Phe Asn 
        35                  40                  45              


Lys Arg Pro Ser Gly Val Pro Asp Arg Phe Ser Gly Ser Gly Ser Gly 
    50                  55                  60                  


Gly Thr Ala Ser Leu Thr Ile Thr Gly Leu Gln Asp Asp Asp Asp Ala 
65                  70                  75                  80  


Glu Tyr Phe Cys Trp Ala Tyr Glu Ala Phe Gly Gly Gly Thr Lys Leu 
                85                  90                  95      


Thr Val Leu 
            


<210> 36
<211> 100
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 36
Gln Ser Ala Leu Thr Gln Pro Arg Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Val Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Gly Tyr 
            20                  25                  30          


Asn Tyr Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Met Ile Tyr Asp Val Ser Lys Arg Pro Ser Gly Val Pro Asp Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Cys Ser Tyr Ala Gly Ser 
                85                  90                  95      


Tyr Thr Phe His 
            100 


<210> 37
<211> 94
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 37
Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln 
1               5                   10                  15      


Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Ser Tyr 
            20                  25                  30          


Asn Leu Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu 
        35                  40                  45              


Met Ile Tyr Glu Gly Ser Lys Arg Pro Ser Gly Val Ser Asn Arg Phe 
    50                  55                  60                  


Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu 
65                  70                  75                  80  


Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Cys Ser Tyr Ala 
                85                  90                  


<210> 38
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 38
Trp Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu 
1               5                   10          


